Would you consider adding pembrolizumab to chemoradiation for locally advanced cervical cancer in a patient with cirrhosis (elevated bilirubin (<3x ULN) and mild LFT elevation), ascites, and signs of portal hypertension?

Would you add immunotherapy to systemic chemotherapy if they have stage IVB disease? Does PLD1 status change your recommendation?